AVITA Medical, Inc. (RCEL) Operating Leases (2020 - 2026)

AVITA Medical (RCEL) has reported Operating Leases for 7 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 23.19% year-over-year to $1.8 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 million (down 23.19% YoY), and the FY2025 full-year result was $2.1 million, down 24.82% from the prior year.
• Operating Leases eased to $1.8 million in Q2 2026 per RCEL's latest filing, from $2.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $3.3 million in Q2 2024 and bottomed at $306000.0 in Q4 2022.
• Historically, Operating Leases has averaged $1.8 million across 5 years, with a median of $1.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Leases tumbled 66.67% in 2022, then soared 456.21% in 2023.
• Over 5 years, Operating Leases stood at $306000.0 in 2022, then jumped by 456.21% to $1.7 million in 2023, then surged by 66.86% to $2.8 million in 2024, then dropped by 24.82% to $2.1 million in 2025, then dropped by 14.66% to $1.8 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $1.8 million, $2.1 million, and $2.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.